TOP TIERMARKET NEWSWIRE
SEC Form 4 history

INTELLIA THERAPEUTIC (NTLA) insider trades

INTELLIA THERAPEUTIC (NTLA) insider trading activity (SEC Form 4). Over the trailing 90 days, NTLA insiders filed 0 purchases totalling $0 and 3 sales totalling $418K — net SELLING of $418K. Most recent filing: Nov 3, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
3
$418K
Net (90d)
-$418K
net selling
Most recent
Nov 3, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Nov 3, 2026Leonard John MPres, CEOS Sale—$11.99$108Kfiling
Oct 6, 2026Dube Michael PVP, Chief Accounting OfficerS Sale—$12.43$23Kfiling
Aug 24, 2026Leonard John MPres, CEOS Sale—$12.65$287Kfiling
Jul 24, 2026Dulac Edward J IIIEVP, CFOS Sale—$11.25$91Kfiling
Jul 6, 2026Dulac Edward J IIIEVP, CFOS Sale—$18.00$84Kfiling
Jul 6, 2026Dube Michael PVP, Chief Accounting OfficerS Sale—$16.78$44Kfiling